Gillian Zipursky

Gillian Zipursky

Auto-generated profile, based on publicly available information

Gillian Zipursky

Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2022 in Science Advances
Verified
Journal Article
Open access
TMTara C. Marcink
Tara C. Marcink
TKThomas Kicmal
Thomas Kicmal
EAEmily Armbruster
Emily Armbruster
ZZZhening Zhang
Zhening Zhang
GZGillian Zipursky
Gillian Zipursky
AMAnne Moscona
Anne Moscona
SARS-CoV-2 cell entry is completed after viral spike (S) protein–mediated membrane fusion between viral and host cell membranes. Stable prefusion and postfusion S structures have been resolved by cryo–electron microscopy and cryo–electron tomography, but the refolding intermediates on the fusion pathway are transient and have not been examined. We used an antiviral lipopeptide entry inhibitor to arrest S protein refolding and thereby capture intermediates as S proteins interact with hACE2 and fusion-activating proteases on cell-derived target membranes. Cryo–electron tomography imaged both extended and partially folded intermediate states of S2, as well as a novel late-stage conformation on the pathway to membrane fusion. The intermediates now identified in this dynamic S protein–directed fusion provide mechanistic insights that may guide the design of CoV entry inhibitors.

10 February 2023 in Science Advances
Verified
Journal Article
Closed access
TMTara C. Marcink
Tara C. Marcink
GZGillian Zipursky
Gillian Zipursky
WCWenjing Cheng
Wenjing Cheng
KSKyle Stearns
Kyle Stearns
SSShari Stenglein
Shari Stenglein
AMAnne Moscona
Anne Moscona
Paramyxoviruses—including important pathogens like parainfluenza, measles, and Nipah viruses—use a receptor binding protein [hemagglutinin-neuraminidase (HN) for parainfluenza] and a fusion protein (F), acting in a complex, to enter cells. We use cryo–electron tomography to visualize the fusion complex of human parainfluenza virus 3 (HN/F) on the surface of authentic clinical viruses at a subnanometer resolution sufficient to answer mechanistic questions. An HN loop inserts in a pocket on F, showing how the fusion complex remains in a ready but quiescent state until activation. The globular HN heads are rotated with respect to each other: one downward to contact F, and the other upward to grapple cellular receptors, demonstrating how HN/F performs distinct steps before F activation. This depiction of viral fusion illuminates potentially druggable targets for paramyxoviruses and sheds light on fusion processes that underpin wide-ranging biological processes but have not been visualized in situ or at the present resolution.

28 June 2024 in Science
Verified
Journal Article
Closed access
DZDawid S Zyla
Dawid S Zyla
RMRoberta Della Marca
Roberta Della Marca
GNGele Niemeyer
Gele Niemeyer
GZGillian Zipursky
Gillian Zipursky
KSKyle Stearns
Kyle Stearns
ESErica Ollmann Saphire
Erica Ollmann Saphire
Measles virus (MeV) presents a public health threat that is escalating as vaccine coverage in the general population declines and as populations of immunocompromised individuals, who cannot be vaccinated, increase. There are no approved therapeutics for MeV. Neutralizing antibodies targeting viral fusion are one potential therapeutic approach but have not yet been structurally characterized or advanced to clinical use. We present cryo–electron microscopy (cryo-EM) structures of prefusion F alone [2.1-angstrom (Å) resolution], F complexed with a fusion-inhibitory peptide (2.3-Å resolution), F complexed with the neutralizing and protective monoclonal antibody (mAb) 77 (2.6-Å resolution), and an additional structure of postfusion F (2.7-Å resolution). In vitro assays and examination of additional EM classes show that mAb 77 binds prefusion F, arrests F in an intermediate state, and prevents transition to the postfusion conformation. These structures shed light on antibody-mediated neutralization that involves arrest of fusion proteins in an intermediate state.